179 related articles for article (PubMed ID: 31596979)
1. The continual impact of the Paris System on urine cytology, a 3-year experience.
Stanzione N; Ahmed T; Fung PC; Cai D; Lu DY; Sumida LC; Moatamed NA
Cytopathology; 2020 Jan; 31(1):35-40. PubMed ID: 31596979
[TBL] [Abstract][Full Text] [Related]
2. The Paris System for Reporting Urinary Cytology reduces atypia rates and does not alter the negative predictive value of urine cytology.
McIntire PJ; Kilic I; Pambuccian SE; Wojcik EM; Barkan GA
J Am Soc Cytopathol; 2021; 10(1):14-19. PubMed ID: 33221245
[TBL] [Abstract][Full Text] [Related]
3. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
Pastorello RG; Barkan GA; Saieg M
J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
[TBL] [Abstract][Full Text] [Related]
4. Two-year study on the application of the Paris system for urinary cytology in a cancer centre.
de Paula R; Oliveira A; Nunes W; Bovolim G; Domingos T; De Brot L; Bezerra S; Cunha I; Morini M; Saieg M
Cytopathology; 2020 Jan; 31(1):41-46. PubMed ID: 31654587
[TBL] [Abstract][Full Text] [Related]
5. The utility of upper urinary tract urine cytology before and after application of the Paris system.
Simon CT; Skala SL; Magers MJ; Weizer A; Kaffenberger SD; Chinnaiyan AM; Spratt DE; Montgomery J; Mehra R; Lew M
Diagn Cytopathol; 2019 May; 47(5):421-427. PubMed ID: 30569543
[TBL] [Abstract][Full Text] [Related]
6. Urinary tract cytology: a cytologic-histopathologic correlation with The Paris System, an institutional study.
Danakas A; Sweeney M; Cheris S; Agrawal T
J Am Soc Cytopathol; 2021; 10(1):56-63. PubMed ID: 33132054
[TBL] [Abstract][Full Text] [Related]
7. Applying the Paris system for reporting urine cytology to challenging cytology cases.
Glass R; Rosca O; Raab S; Szabelska J; Chau K; Sheikh-Fayyaz S; Cocker R
Diagn Cytopathol; 2019 Jul; 47(7):675-681. PubMed ID: 31017746
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based diagnostic accuracy measurement in urine cytology using likelihood ratios.
Myles N; Auger M; Kanber Y; Caglar D; Kassouf W; Brimo F
J Am Soc Cytopathol; 2021; 10(1):71-78. PubMed ID: 33071190
[TBL] [Abstract][Full Text] [Related]
9. Improved diagnostic precision of urine cytology by implementation of The Paris System and the use of cell blocks.
Chan E; Balassanian R; Tabatabai ZL; Lou H; Vohra P
Cancer Cytopathol; 2018 Sep; 126(9):809-816. PubMed ID: 30203925
[TBL] [Abstract][Full Text] [Related]
10. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas.
McIntire PJ; Snow JT; Robinson BD; Rao RA; Goyal A; Heymann JJ; Siddiqui MT
Cancer Cytopathol; 2018 Jul; 126(7):498-504. PubMed ID: 29927548
[TBL] [Abstract][Full Text] [Related]
11. Outcome analysis and negative predictive value of the "unsatisfactory/nondiagnostic" category of The Paris System for Reporting Urinary Cytology.
Abro S; Nomani L; Wojcik EM; Pambuccian SE; Chatt G; Barkan GA
J Am Soc Cytopathol; 2021; 10(1):64-70. PubMed ID: 33279453
[TBL] [Abstract][Full Text] [Related]
12. The Paris System "atypical urothelial cells" category: can the current criteria be improved?
Vosoughi A; Ordobazari A; Lora Gonzalez MA; Guido LP; Skiba M; Campuzano-Zuluaga G; Kryvenko ON; Gomez-Fernandez C; Garcia-Buitrago M; Jorda M
J Am Soc Cytopathol; 2021; 10(1):3-8. PubMed ID: 32732113
[TBL] [Abstract][Full Text] [Related]
13. Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system.
Rohilla M; Singh P; Rajwanshi A; Gupta N; Srinivasan R; Dey P; Kakkar N
Cytopathology; 2018 Oct; 29(5):436-443. PubMed ID: 29920811
[TBL] [Abstract][Full Text] [Related]
14. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
Vlajnic T; Gut A; Savic S; Bubendorf L
J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
[TBL] [Abstract][Full Text] [Related]
15. Utility of the Paris System in Reporting Urine Cytology.
Malviya K; Fernandes G; Naik L; Kothari K; Agnihotri M
Acta Cytol; 2017; 61(2):145-152. PubMed ID: 28380477
[TBL] [Abstract][Full Text] [Related]
16. Application of The Paris System in neobladder washing cytology: Comparison between the original diagnosis and correlation with histopathology.
Kim JM; Lee J; Sung SH
Diagn Cytopathol; 2023 Dec; 51(12):744-750. PubMed ID: 37610033
[TBL] [Abstract][Full Text] [Related]
17. The Paris system classification for urinary cytology in patients under bacillus Calmette-Guerin treatment.
Moulavasilis N; Stravodimos K; Meletis E; Levis P; Leftheriotis V; Lazaris A; Constantinides C; Mikou P
Diagn Cytopathol; 2022 Jun; 50(6):289-294. PubMed ID: 35262275
[TBL] [Abstract][Full Text] [Related]
18. Risk of malignancy assessment for the Paris System for reporting urinary cytology.
Moulavasilis N; Lazaris A; Katafigiotis I; Stravodimos K; Constantinides C; Mikou P
Diagn Cytopathol; 2020 Dec; 48(12):1194-1198. PubMed ID: 32762032
[TBL] [Abstract][Full Text] [Related]
19. Comparison of urine cytology diagnostic reports before and after the implementation of the Paris System classification system in China.
Ma C; Zhang L
Cytopathology; 2020 Sep; 31(5):457-462. PubMed ID: 32246545
[TBL] [Abstract][Full Text] [Related]
20. Targeted education as a method for reinforcing Paris System criteria and reducing urine cytology atypia rates.
Compton ML; Weiss VL; Barkan GA; Ely KA
J Am Soc Cytopathol; 2021; 10(1):9-13. PubMed ID: 32771394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
